ABOUT US Towards better quality of life, GNT Pharma


GNTP is a biopharmaceutical company established in April 1998 with the aim of developing innovative medicines and technologies for the treatment of neurological disorders such as stroke and Alzheimer’s disease.

While new drug development for brain diseases has traditionally targeted an individual identified disease mechanism, GNT has focused its efforts on "multi-targeting" multiple concurrent disease mechanisms, an approach proven effective and sometimes even necessary in other fields such as cancer.

  • Mission
    GNTP will contribute to the health and well-being of mankind by developing innovative and effective new drugs and technologies for the treatment of debilitating brain diseases.
  • Vision
    By discovering and launching drugs targeting cerebrovascular diseases, degenerative brain diseases, and chronic inflammatory - respiratory diseases, GNTP will not only contribute to improving the health and welfare of patients, but also grow into a global innovative biopharmaceutical company that will significantly ease the economic burden on patients, care givers, families, and society.


  • Drag from side to side.


Core Values POINTS


    We will aim high with a bold pioneering spirit.


    We will pursue our goals with confidence and positivity.


    We will innovate to address the healthcare needs of mankind.


    We will develop talent with mutual encouragement and support.


    We will strive to act truthfully and with appropriate intent.


    We will do our best to be diligent in all endeavors.